Please try another search
For the fiscal year ended 30 June 2017, PAREXEL International Corporation revenues increased 1% to $2.44B. Net income decreased 31% to $107.3M. Revenues reflect Parexel's Consulting Services segment increase of 10% to $210.3M, Perceptive Informatics, Inc. segment increase of 1% to $280.7M, Clinical Reserach Services segment remaining flat at $1.63B, Asia/Pacific segment increase of 16% to $343.7M, North America segment increase of 2% to $998.3M.
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Revenue | 647.6 | 605.2 | 612.2 | 576.5 |
Gross Profit | 207.9 | 179.5 | 184.2 | 169.1 |
Operating Income | 48 | 29.9 | 60 | 53.3 |
Net Income | 29.9 | 17.8 | 21.8 | 37.8 |
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Assets | 2218.5 | 2246.4 | 2081 | |
Total Liabilities | 1650.8 | 1711.3 | 1391.6 | |
Total Equity | 567.7 | 535.1 | 689.4 |
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Period Length: | 0 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | 261.5 | 111.5 | 65.4 | |
Cash From Investing Activities | -241.3 | -181.5 | -18.5 | |
Cash From Financing Activities | 17.4 | 89.2 | 26.3 | |
Net Change in Cash | 35.7 | 3.8 | 77.2 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review